SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in DGX — Quest Diagnostics Inc
CIK 1232395
NEW YORK, NY
Position in DGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,893,911
+$4,403,639 QoQ
Shares Held
126,888
+10.6% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#92
of 1,095 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $174,115,729 across 14 Diagnostics & Research names. DGX ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
104,046 | $52,164,502 | |
| 2 | DGX |
Quest Diagnostics Inc
This page
|
126,888 | $26,893,911 | |
| 3 | RDNT |
RadNet, Inc.
|
351,756 | $21,692,792 | |
| 4 | TWST |
Twist Bioscience Corp
|
196,496 | $20,215,508 | |
| 5 | DHR |
Danaher Corp /De/
|
98,198 | $18,704,755 | |
| 6 | A |
Agilent Technologies, Inc.
|
79,608 | $10,574,330 | |
| 7 | CDNA |
CareDx, Inc.
|
296,200 | $8,441,700 | |
| 8 | CSTL |
Castle Biosciences Inc
|
256,095 | $6,107,865 |
All Filings in DGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,893,911 | 126,888 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,490,272 | 114,758 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,478,916 | 112,251 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,838,207 | 109,341 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,404,710 | 108,026 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,285,444 | 108,070 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,177,570 | 80,721 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $251,815 | 1,622 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $222,019 | 1,622 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $229,215 | 1,722 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $237,980 | 1,726 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $210,330 | 1,726 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $242,606 | 1,726 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $254,098 | 1,796 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $280,966 | 1,796 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $220,351 | 1,796 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $238,832 | 1,796 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $245,800 | 1,796 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $312,629 | 1,807 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $231,914 | 1,596 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $210,624 | 1,596 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $204,830 | 1,596 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||